"10.1371_journal.pone.0112658","plos one","2014-11-13T00:00:00Z","Elena G Kamburova; Hans J P M Koenen; Martijn W F van den Hoogen; Marije C Baas; Irma Joosten; Luuk B Hilbrands","Department of Laboratory Medicine - Medical Immunology, Radboud University Medical Centre, Nijmegen, The Netherlands; Department of Nephrology, Radboud University Medical Centre, Nijmegen, The Netherlands","Conceived and designed the experiments: EGK HJPMK MWFvdH MCB IJ LBH. Performed the experiments: EGK. Analyzed the data: EGK HJPMK MCB IJ LBH. Contributed to the writing of the manuscript: EGK HJPMK MCB IJ LBH. Provided patient data: MWFvdH LBH.","The authors of this manuscript have read the journals policy and have the following competing interests: LBH has received research funds from Roche, the manufacturer of rituximab. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials. The other authors have declared that no competing interests exist.","2014","11","Elena G Kamburova","EGK",6,FALSE,NA,NA,NA,NA,NA,NA,NA,NA,NA
